Publications related only Cancer :  Page, D. B., Broeckx, G., Jahangir, C. A., Verbandt, [...], Najat Bouchmaa, S., Gupta, R. R., Thagaard, J., ... & Specht Stovgaard, E. (2023). Spatial analyses of immune cell infiltration in cancer: current methods and future directions: A report of the International Immuno‐Oncology Biomarker Working Group on Breast Cancer. The Journal of pathology, 260(5), 514-532.  Thagaard, J., Broeckx, G., Page, D. B., Jahangir, C. A., [...], Najat Bouchmaa, Octavio Burgues,…& Specht Stovgaard, E. (2023). Pitfalls in machine learning‐based assessment of tumor‐infiltrating lymphocytes in breast cancer: A report of the International Immuno‐Oncology Biomarker Working Group on Breast Cancer. The Journal of pathology, 260(5), 498-513.  Idir, A., Bouchmaa, N., El Abbouchi, A., El Brahmi, N., Mrid, R. B., Bouargalne, Y., ... & Zyad, A. (2023). In vitro cytotoxic, antioxidant, hemolytic and cytoprotective potential of promising ethacrynic acid derivatives. Moroccan Journal of Chemistry, 11(3).  Bouchmaa, N., Ben Mrid, R., Bouargalne, Y., Ajouaoi, S., Cacciola, F., El Fatimy, R., ... & Zyad, A. (2023). In vitro evaluation of dioscin and protodioscin against ER-positive and triple-negative breast cancer. Plos one, 18(2), e0272781.  Kabach, I., Bouchmaa, N., Ben Mrid, R., Zouaoui, Z., Maadoudi, M. E., Kounnoun, A., ... & Nhiri, M. (2022). Olea europaea var. Oleaster a promising nutritional food with in vitro antioxidant, antiglycation, antidiabetic and antiproliferative effects. Journal of Food Measurement and Characterization, 1-13.  Ben Mrid, R.*, Bouchmaa, N.*, Ouedrhiri, W., Ennoury, A., ZouaouI, Z., Kabach, I., ... & El Fatimy, R. (2022). Synergistic antioxidant effects of natural compounds on H2O2-induced cytotoxicity of human monocytes. Frontiers in pharmacology, 3367. (Equal contribution)  El Khayari, A., Bouchmaa, N., Taib, B., Wei, Z., Zeng, A., & El Fatimy, R. (2022). Metabolic Rewiring in Glioblastoma Cancer: EGFR, IDH and Beyond. Front. Oncol, 12, 901951.  Bouchmaa, N*., Ben Mrid, R., Kabach, I., Zouaoui, Z., Karrouchi, K., Chtibi, H., ... & Nhiri, M. (2022). Beta vulgaris subsp. maritima: A Valuable Food with High Added Health Benefits. Applied Sciences, 12(4), 1866.  Ben Mrid, R* & Bouchmaa, N*., Kabach, I., Zouaoui, Z., Chtibi, H., Maadoudi, M. E., ... & Nhiri, M. (2022). Dittrichia viscosa L. Leaves: A Valuable Source of Bioactive Compounds with Multiple Pharmacological Effects. Molecules, 27(7), 2108. (Equal contribution)  EL Bairi, K., Haynes, H. R., Blackley, E., Fineberg, S., Shear, J., Turner, S., ...Najat Bouchmaa, … & Loi, S. (2021). The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group. NPJ Breast Cancer-Nature, 7(1), 1-17.  Kabach, R. Ben Mrid, N. Bouchmaa, Y. Bouargalne, M. Nhiri (2018). Phytochemical screening, antioxidant, and cytotoxicity activities of M. vulgare. International Journal of Pharmaceutical Research, 11(3), 338-345.  S. Ajouaoi, N. Bouchmaa, A. Idir, O. Mernari, H. Ait Mouse and A. Zyad (2019). Treatment with lead chloride during pregnancy and the postnatal period alters cell proliferation and immune function in Swiss Albino mice. Biological Trace Element Research. DOI: 10.1007/s12011-019-01917-x.  N. Bouchmaa*, R. Ben mrid, Y. Boukharsa, Y. Bouargalne, M. Nhiri, A. Idir, J. Taoufik, M. Ansar & Abdelmajid Zyad (2018). Reactive Oxygen Species-Mediated Apoptosis and Cytotoxicity of Newly Synthesized Pyridazin-3-Ones In P815 (murin mastocytoma) cell line. Drug Research, 2019, 69: 1–9.  R. Ben Mrid* & N. Bouchmaa*, Y. Bouargalne, K. Karrouchi, I. Kabach, M. El Karbane, A. Idir, A. Zyad and Mohamed Nhiri (2019). Phytochemical Characterization, Antioxidant, and In Vitro Cytotoxic Activity Evaluation of Juniperus oxycedrus Subsp. oxycedrus Needles and Berries. Molecules, 24, 502. (Equal contribution)  N. Bouchmaa*, R. Ben Mrid, Y. Boukharsa, M. Nhiri, H. Ait Mouse, J. Taoufik, M. Anssar and A. Zyad (2018). Cytotoxicity of Newly Pyridazin-3(2H)-One Derivatives Orchestrating Oxidative Stress in Human Triple Negative Breast Cancer (MDA-MB-468). Arch Pharm Chem Life Sci., 2018, 1–11.  N. Bouchmaa*, M. Tilaoui, Y. Boukharsa, A. Jaâfari, H. Aît Mouse, M. A. Oukerrou, J. Taoufik, M. Ansar and A. Zyad (2017). In Vitro Antitumor Activity of Newly Synthesized Pyridazin-3(2H)-One Derivatives via Apoptosis Induction. Pharmaceutical Chemistry Journal, 51(10), 893-901.  M. A. Oukerrou, M. Tilaoui, H. Ait Mouse, N. Bouchmaa, A. Zyad (2017). Differential Cytotoxic Activity of Essential Oil of Lippia citriodorafrom Different Regions in Morocco. Chemistry & biodiversity, 14(7), e1600497. INTERNATIONALE PATENT  M. Ansar, A. Zyad, N. Bouchmaa, Y. Boukharsa, Y. Zaoui, A. Ibrahimi et J. Taoufik. ANTICANCER EFFET OF NEW DERIVATIVES OF 5 ARYLIDERE-6- METHYLPYRIDAZIN-3(2H) -ONES AGAINST TRIPLE NEGATIVE BREAST CANCER (2018). N° of Publication: MA 38025 A1. Cl. Internationale: A61K 31/5025.